Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial in Relapsed Ovarian Cancer: Early Treatment Based on CA 125 Levels Alone Vs. Delayed Treatment Based On Conventional Clinical Indicators

NCT00002895 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00002895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial in Relapsed Ovarian Cancer: Early Treatment Based on CA 125 Levels Alone Vs. Delayed Treatment Based On Conventional Clinical Indicators
Lead sponsor
Medical Research Council
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1996
Completion date
October 31, 2010
Enrollment
1,400 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer